Daniel G. Baker

Insider Reports History

Location
Boston, MA
Signature
/s/ Daniel G. Baker by Colin Sandercock, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel G. Baker:

Company Role Class Num Shares Value Price $ Report Date Ownership
Shattuck Labs, Inc. Director Stock Option (Right to Buy) 66,300 28 Aug 2025 Direct
Cue Biopharma, Inc. CHIEF DEVELOPMENT OFFICER Stock Option (right to buy) 50,000 29 Sep 2025 Direct
Artiva Biotherapeutics, Inc. Director Director Stock Option (Right to Buy) 13,750 24 Jun 2025 Direct

Insider Reports Filed by Daniel G. Baker

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CUE Cue Biopharma, Inc. 29 Sep 2025 1 $0 4 CHIEF DEVELOPMENT OFFICER 25 Nov 2025, 16:00
STTK Shattuck Labs, Inc. 28 Aug 2025 1 $0 4 Director 02 Sep 2025, 06:35
STTK Shattuck Labs, Inc. 25 Aug 2025 0 $0 3 Director 02 Sep 2025, 06:30
ARTV Artiva Biotherapeutics, Inc. 24 Jun 2025 1 $0 4 Director 26 Jun 2025, 16:30
CUE Cue Biopharma, Inc. 21 Mar 2025 1 $0 4 CHIEF DEVELOPMENT OFFICER 25 Mar 2025, 16:00
ARTV Artiva Biotherapeutics, Inc. 28 Jan 2025 1 $0 4 Director 29 Jan 2025, 16:33
ARTV Artiva Biotherapeutics, Inc. 28 Jan 2025 0 $0 3 Director 29 Jan 2025, 16:32
CUE Cue Biopharma, Inc. 25 Nov 2024 1 $0 4 CHIEF DEVELOPMENT OFFICER 29 Nov 2024, 16:00
CUE Cue Biopharma, Inc. 25 Nov 2024 0 $0 3 CHIEF DEVELOPMENT OFFICER 29 Nov 2024, 16:00